MANUSCRIPT SUBMISSION

Drug Development & Delivery welcomes objective, well-balanced manuscripts that describe emerging or steadfast drug development techniques and information and their practical application to professionals in industry, academia, and government. Manuscripts should be forwarded with the understanding that they have not been published previously and are not under consideration for publication elsewhere.

Authors are responsible for all statements made in their work. All manuscripts are subject to peer review and copyediting. Authors of accepted papers will have an opportunity to review galleys. Upon acceptance, copyright of the manuscript is transferred to Drug Development & Delivery. If illustrations or other material in a manuscript have been published previously, the author is responsible for obtaining permission to republish. Rejected manuscripts are returned upon request. Drug Development & Delivery is not responsible for loss of materials.

MANUSCRIPT PREPARATION
(2,500 words maximum)

For papers with multiple authors, designate a single author to handle correspondence. Include this author's full mailing address, telephone number, fax number, and e-mail address in the cover letter that accompanies the manuscript. Manuscripts must be typewritten (double-spaced) with liberal margins and space at the top and bottom of the page. The following should appear on separate pages with appropriate headings:

  • Title page (with each author's name, affiliation, and title)
  • Abstract or introduction
  • Organized body of article (with headings where appropriate)
  • References (follow AMA manual of style)
  • Author(s) bio(s), including current title and place of employment, academic and association affiliations/honors, schooling and related degrees, and other specifically related accomplishments, achievements (60-word maximum for each author)
  • Captions for illustrations, charts, tables, photos, etc.

*Please send color digital photo of author(s).

Visuals--Electronic/digital (JPEG) photos, visuals, illustrations, charts, graphs, etc (along with printed versions) should be sent via E-mail.

Dan Marino, MSc
Executive Director
Drug Development & Delivery
219 Changebridge Road
Montville, NJ
07045
Telephone: (973) 299-1200
Fax: (973) 299-7937
E-mail: dmarino@drug-dev.com























- SHL


Click here to see the showcases


INTERPHEX
March 21-23
New York, NY

PDA Annual Meeting
April 3-5
Anaheim, CA

RDD (Respiratory Drug Delivery)
April 25-28
Nice, France

Pre-filled Syringes East Coast
April 26-27
Boston, MA


AAPS National Biotechnology Meeting
May 1-3
San Diego, CA

Innovation Networking Summit & Table-top Exhibition
May 4-5
Hilton Hotel, Parsippany, NJ

CPhI North America & Informex
May 16-18
2017 Philadelphia, PA

BIO 2017
June 19 - 22
San Diego, CA

Controlled Release Society Meeting
July 16-19 Boston, MA

CPhI Worldwide
October 24-26
Frankfurt, Germany

Universe of Prefilled Syringes & Injection Devices Europe
November 7-8
Nienna, Austria

AAPS
November 12-17
San Diego, CA

 



Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions